Evidence map›Paper›PMID 33573473›Full record

ArticleThe neuroradiology journal2021

T2 mapping of the peritumoral infiltration zone of glioblastoma and anaplastic astrocytoma.

Timo Alexander Auer, Maike Kern, Uli Fehrenbach, Yasemin Tanyldizi, Martin Misch, Edzard Wiener

Abstract read
In one paragraph

Article in The neuroradiology journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Imaging in translational cancer research.Cancer biology & medicine · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Timo Alexander AuerDepartment of Radiology, Charité University Hospital, Berlin, Germany.ORCID https://orcid.org/0000-0002-5763-689X
Maike KernDepartement for Neuroradiology, Charite - University Hospital Berlin, Berlin, Germany.
Uli FehrenbachDepartement for Neuroradiology, Charite - University Hospital Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0003-3622-3268
Yasemin TanyldiziDepartment of Neuroradiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Martin MischDepartment of Neurosurgery, Charité University Hospital, Berlin, Germany.
Edzard WienerDepartement for Neuroradiology, Charite - University Hospital Berlin, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo characterise peritumoral zones in glioblastoma and anaplastic astrocytoma evaluating T2 values using T2 mapping sequences. MATERIALS AND

methodsIn this study, 41 patients with histopathologically confirmed World Health Organization high grade gliomas and preoperative magnetic resonance imaging examinations were retrospectively identified and enrolled. High grade gliomas were differentiated: (a) by grade, glioblastoma versus anaplastic astrocytoma; and (b) by isocitrate dehydrogenase mutational state, mutated versus wildtype. T2 map relaxation times were assessed from the tumour centre to peritumoral zones by means of a region of interest and calculated pixelwise by using a fit model.

resultsSignificant differences between T2 values evaluated from the tumour centre to the peritumoral zone were found between glioblastoma and anaplastic astrocytoma, showing a higher decrease in signal intensity (T2 value) from tumour centre to periphery for glioblastoma (

conclusionPeritumoral T2 mapping relaxation time tissue behaviour of glioblastoma differs from anaplastic astrocytoma. Significant differences in T2 values, using T2 mapping relaxation time, were found between glioblastoma and anaplastic astrocytoma, capturing the tumour centre to the peritumoral zone. A similar curve progression from tumour centre to peritumoral zone was found for isocitrate dehydrogenase wildtype high grade gliomas in comparison to isocitrate dehydrogenase mutated high grade gliomas. This finding is in accordance with the biologically more aggressive behaviour of isocitrate dehydrogenase wildtype in comparison to isocitrate dehydrogenase mutated high grade gliomas. These results emphasize the potential of mapping techniques to reflect the tissue composition of high grade gliomas.

Indexed as

AstrocytomaBrain NeoplasmsGlioblastomaHumansIsocitrate DehydrogenaseMagnetic Resonance ImagingMutationRetrospective StudiesIsocitrate DehydrogenaseGlioblastomagliomaMRI (magnetic resonance imaging)multiparametric imagingT2 mapping

Identifiers

PMID33573473
PMCPMC8551439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.